Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T G Aigner

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Psychopharmacology|January 1, 1988
Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeysT G Aigner
Current Opinion in Neurobiology|April 1, 1995
Pharmacology of memory: cholinergic-glutamatergic interactionsT G Aigner
Psychopharmacology|January 1, 1988
Improved recognition memory in monkeys following naloxone administrationT G Aigner, M Mishkin
Neuroreport|January 31, 1996
Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeysN Matsuoka, T G Aigner
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmineN Matsuoka, T G Aigner
Brain Research|August 26, 1996
The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeysN Matsuoka, T G Aigner
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugsH Ogura, T G Aigner
Behavioral and Neural Biology|January 1, 1986
The effects of physostigmine and scopolamine on recognition memory in monkeysT G Aigner, M Mishkin
Behavioural Brain Research|April 30, 1993
Scopolamine impairs recall of one-trial stimulus-reward association in monkeysT G Aigner, M Mishkin
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeysN Matsuoka, T G Aigner
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Psychopharmacology|January 1, 1988
Delta-9-tetrahydrocannabinol impairs visual recognition memory but not discrimination learning in rhesus monkeysT G Aigner
Current Opinion in Neurobiology|April 1, 1995
Pharmacology of memory: cholinergic-glutamatergic interactionsT G Aigner
Psychopharmacology|January 1, 1988
Improved recognition memory in monkeys following naloxone administrationT G Aigner, M Mishkin
Neuroreport|January 31, 1996
Cholinergic-glutamatergic interactions in visual recognition memory of rhesus monkeysN Matsuoka, T G Aigner
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1997
FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmineN Matsuoka, T G Aigner
Brain Research|August 26, 1996
The glycine/NMDA receptor antagonist HA-966 impairs visual recognition memory in rhesus monkeysN Matsuoka, T G Aigner
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1993
MK-801 impairs recognition memory in rhesus monkeys: comparison with cholinergic drugsH Ogura, T G Aigner
Behavioral and Neural Biology|January 1, 1986
The effects of physostigmine and scopolamine on recognition memory in monkeysT G Aigner, M Mishkin
Behavioural Brain Research|April 30, 1993
Scopolamine impairs recall of one-trial stimulus-reward association in monkeysT G Aigner, M Mishkin
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1996
D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeysN Matsuoka, T G Aigner
Pageof 4